Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China flag China · Delayed Price · Currency is CNY
13.21
+0.23 (1.77%)
Sep 30, 2026, 3:04 PM CST

SHE:300181 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
648.24680.88804.67931.981,082232.3
Trading Asset Securities
---15110.8365.52
Cash & Short-Term Investments
648.24680.88804.671,0831,093297.82
Cash Growth
-11.36%-15.38%-25.70%-0.91%266.97%-5.39%
Accounts Receivable
1,2471,139783.33532.42510.07337.33
Other Receivables
14.5218.0118.189.0224.4226.77
Receivables
1,2611,157801.52541.44534.5364.1
Inventory
570.56531.81523.75426.52318.83273.59
Prepaid Expenses
0.183.970-7.87-
Other Current Assets
43.1717.2447.515.535.456.16
Total Current Assets
2,5232,3912,1772,0561,960941.67
Property, Plant & Equipment
1,4801,4271,2201,060972.41806.32
Long-Term Investments
382.27411.57254.64179.7392.36650.67
Goodwill
321.37130.32130.32130.32130.32130.32
Other Intangible Assets
275.7182.4275.0871.2763.0464.89
Long-Term Deferred Tax Assets
32.7131.7930.425.525.1415.51
Long-Term Deferred Charges
60.5350.0935.5825.4925.4225.6
Other Long-Term Assets
122.53186.7268.9178.0774.76113.55
Total Assets
5,1984,7123,9923,6273,6432,749

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
537.1425.26482.41433.85468.88296.77
Accrued Expenses
86.28127.2586.5382.2478.3262.33
Short-Term Debt
713.3660.09377.31193.06138.16178.2
Current Portion of Long-Term Debt
---10.010.01-
Current Portion of Leases
4.143.193.352.492.834.21
Current Income Taxes Payable
57.2669.2652.5432.6526.5916.46
Current Unearned Revenue
11.15.2614.452.2314.143.06
Other Current Liabilities
244.3448.6439.4638.282623.55
Total Current Liabilities
1,6541,3391,056794.83754.94584.58
Long-Term Debt
46.6611.6630.66-10-
Long-Term Leases
17.5917.0718.2716.6922.1324.27
Long-Term Unearned Revenue
28.0727.6526.519.919.7622.37
Long-Term Deferred Tax Liabilities
67.777541.0321.6876.24134.1
Total Liabilities
1,8141,4701,173853.09883.07765.31

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
701.39701.39701.39701.39701.39608.62
Additional Paid-In Capital
1,1451,1421,1351,1351,135340.48
Retained Earnings
1,3891,2571,041849.32676.8525.52
Treasury Stock
-81.45-111.88-203.97---
Comprehensive Income & Other
171.39191.6294.6342.66190.19369.44
Total Common Equity
3,3263,1802,7692,7292,7041,844
Minority Interest
58.7561.2550.5645.256.18139.15
Shareholders' Equity
3,3853,2412,8192,7742,7601,983
Total Liabilities & Equity
5,1984,7123,9923,6273,6432,749

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
781.69692.01429.59222.25173.13206.67
Net Cash (Debt)
-133.45-11.13375.08860.73919.7791.15
Net Cash Growth
---56.42%-6.42%909.09%-
Net Cash Per Share
-0.19-0.020.541.241.520.15
Filing Date Shares Outstanding
695.44693.22692.47701.39701.39608.62
Total Common Shares Outstanding
695.44693.22686.49701.39701.39608.62
Working Capital
869.871,0521,1211,2621,205357.1
Book Value Per Share
4.784.594.033.893.853.03
Tangible Book Value
2,7292,9672,5632,5272,5101,649
Tangible Book Value Per Share
3.924.283.733.603.582.71
Buildings
1,2911,2231,014962.71832.63678.11
Machinery
714.5580.69529.12467.55432.59412.82
Construction In Progress
64.31173.97161.4361.1478.0640.29